COMP <GO>
FBIO vs ZYBT // RSI-14 & 200D SMA MOMENTUM
Fortress Biotech Inc. (NASDAQ) VS. Zhengye Biotechnology Holding Limited (Class A) (NASDAQ) • 15-METRIC TALLY: FBIO 5
— ZYBT 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ZYBT
LAST: $1.92 (-4.00%) • MKT CAP: $66.7M
rsi-technicals
38.7
LAST: $1.30 (-9.09%) • MKT CAP: $67.8M
rsi-technicals
43.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FBIO VS. ZYBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FBIO | ZYBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | 20.50% | +46.40 | FBIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -22.30% | -12.70 | ZYBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.61% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | 58.50% | -60.00% | +118.50 | FBIO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | -34.80% | +44.50 | FBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.00% | 0.00% | +1.00 | FBIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.90 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | FBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 38.7 | 43.1 | -4.41 | ZYBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.7M | $67.8M | -$1.1M | ZYBT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FBIO REV | ZYBT REV | FBIO GROSS % | ZYBT GROSS % | FBIO FCF | ZYBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $63.3M | $16.6M | 66.9% | 20.5% | -$65.8M | $1.8M |
| FY 2024 | $57.7M | $25.5M | 63.8% | 49.0% | -$80.2M | $3.8M |
| FY 2023 | $84.5M | — | — | — | -$128.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FBIO // BETA —
ZYBT // BETA —